Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-10-24 |
2024-09 |
-0.08 |
N/A |
N/A |
N/A |
2024-07-29 |
2024-06 |
-0.11 |
-0.13 |
-0.02 |
-18.18% |
2024-04-29 |
2024-03 |
-0.16 |
-0.2 |
-0.04 |
-25.00% |
2024-03-04 |
2023-12 |
-0.11 |
-0.22 |
-0.11 |
-100.00% |
2023-10-26 |
2023-09 |
-0.31 |
-0.24 |
0.07 |
22.58% |
2023-07-27 |
2023-06 |
-0.28 |
-0.31 |
-0.03 |
-10.71% |
Date |
Firm |
Action |
From |
To |
2023-04-27 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2023-03-29 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2022-07-28 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2020-10-29 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2020-08-02 |
Aegis Capital |
Upgrade |
|
Buy |
2020-06-25 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2024-06-05 |
CLOYD MARY ANN |
Director |
220.51K |
Stock Award(Grant) |
2023-08-16 |
DAVIS SCOTT GERALD |
President |
331.37K |
Sale |
2024-03-21 |
JONES JASON C |
Chief Operating Officer |
0.00 |
Stock Award(Grant) |
2024-06-05 |
LATHAN CORINNA |
Director |
226.21K |
Stock Award(Grant) |
2024-06-05 |
LI KECHENG |
Director |
224.74K |
Stock Award(Grant) |
2024-06-05 |
SCHER DEBORAH LAFER |
Director |
78.22K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Essex Investment Management Co LLC |
454.60K |
650.08K |
3.29% |
2023-06-29 |
Vanguard Group Inc |
441.01K |
630.64K |
3.19% |
2023-06-29 |
Geode Capital Management, LLC |
107.83K |
154.20K |
0.78% |
2023-06-29 |
Renaissance Technologies, LLC |
57.61K |
82.38K |
0.42% |
2023-06-29 |
Blackrock Inc. |
55.45K |
79.30K |
0.40% |
2023-06-29 |
Strategic Wealth Investment Group, LLC |
33.91K |
48.50K |
0.25% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
243.39K |
348.04K |
1.76% |
2023-06-29 |
Vanguard Extended Market Index Fund |
179.46K |
256.62K |
1.30% |
2023-05-30 |
Fidelity Extended Market Index Fund |
68.64K |
92.67K |
0.50% |
2023-05-30 |
Fidelity Total Market Index Fund |
14.84K |
20.03K |
0.11% |
2023-06-29 |
Vanguard Institutional Index-Inst Total Stock Market Ind |
14.09K |
20.14K |
0.10% |
2023-05-30 |
Fidelity Series Total Market Index Fund |
11.78K |
15.90K |
0.09% |
Split |
Date |
1 : 15 |
2020-03-25 |
1 : 7 |
2016-05-05 |